Podocyte injury underlies the glomerulopathy of Dahl salt-hypertensive rats and is reversed by aldosterone blocker

Hypertension
Miki NagaseToshiro Fujita

Abstract

Recent clinical studies implicate proteinuria as a key prognostic factor for renal and cardiovascular complications in hypertensives. The pathogenesis of proteinuria in hypertension is, however, poorly elucidated. Podocytes constitute the final filtration barrier in the glomerulus, and their dysfunction may play a pivotal role in proteinuria. In the present study, we examined the involvement of podocyte injury in Dahl salt-hypertensive rats, an animal model prone to hypertensive glomerulosclerosis, and explored the effects of inhibition of aldosterone. Four-week-old Dahl salt-resistant and salt-sensitive rats were fed a 0.3% or 8.0% NaCl diet. Some salt-loaded Dahl salt-sensitive rats were treated with a selective aldosterone blocker eplerenone (1.25 mg/g diet) or hydralazine (0.5 mmol/L). After 6 weeks, salt-loaded Dahl salt-sensitive rats developed severe hypertension, proteinuria, and glomerulosclerosis. Immunostaining for nephrin, a constituent of slit diaphragm, was attenuated, whereas expressions of damaged podocyte markers desmin and B7-1 were upregulated in the glomeruli of salt-loaded Dahl salt-sensitive rats. Electron microscopic analysis revealed podocyte foot process effacement. Podocytes were already impaired at as...Continue Reading

References

Sep 1, 1992·The Journal of Clinical Investigation·R A LafayetteT W Meyer
May 1, 1988·Kidney International·J R Diamond, M J Karnovsky
Jan 15, 1997·The Journal of Clinical Investigation·M E PagtalunanT W Meyer
Nov 13, 1998·The New England Journal of Medicine·G Remuzzi, T Bertani
Dec 2, 1999·Nature Medicine·A K Abbas, A H Sharpe
Dec 10, 1999·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·S BianchiV M Campese
Sep 27, 2000·Journal of the American Society of Nephrology : JASN·Miki NagaseToshiro Fujita
Dec 26, 2001·Journal of the American Society of Nephrology : JASN·Stefan GreiberHermann Pavenstädt
Oct 2, 2002·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Nicole EndlichKarlhans Endlich
Oct 17, 2002·Annals of the New York Academy of Sciences·Ricardo Rocha, John W Funder
Nov 22, 2002·Journal of the American Society of Nephrology : JASN·Peter Mundel, Stuart J Shankland
Dec 31, 2002·Physiological Reviews·Hermann PavenstädtMatthias Kretzler
Apr 5, 2003·Kidney International·Eileen R BlasiEllen G McMahon
Aug 26, 2003·Journal of the American Society of Nephrology : JASN·Shuji ArimaSadayoshi Ito
Nov 8, 2003·Hypertension·Mark J SarnakUNKNOWN American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology,
Dec 17, 2003·Kidney International·Raghu V DurvasulaStuart J Shankland
Jan 30, 2004·Journal of the American Society of Nephrology : JASN·Akira NishiyamaYouichi Abe
Jan 30, 2004·Journal of the American Society of Nephrology : JASN·Marie-Luise GrossEberhard Ritz
May 18, 2004·The Journal of Clinical Investigation·Jochen ReiserPeter Mundel
Jul 20, 2004·Current Hypertension Reports·Olga Gumieniak, Gordon H Williams
Sep 24, 2004·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Young Ki LeeHirashi Kawachi
Nov 17, 2004·The Journal of Clinical Investigation·Jorma WartiovaaraKarl Tryggvason
Mar 23, 2005·Biochemical and Biophysical Research Communications·Masayo HinoToshiro Fujita
May 11, 2005·Kidney International·Takeshi NakatsueHiroshi Kawachi
Sep 30, 2005·Journal of the American Society of Nephrology : JASN·Jean Claude AldigierAgnes B Fogo
Nov 4, 2005·Journal of the American Society of Nephrology : JASN·Liming WangRobert F Spurney
Feb 3, 2006·Journal of the American Society of Nephrology : JASN·Shigeru ShibataToshiro Fujita

❮ Previous
Next ❯

Citations

Apr 26, 2008·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Toshiro Fujita
Nov 20, 2008·Pflügers Archiv : European journal of physiology·Michael Gekle, Claudia Grossmann
May 3, 2013·Pflügers Archiv : European journal of physiology·Amy McCurleyIris Z Jaffe
May 31, 2013·Current Atherosclerosis Reports·Adam P McGrawIris Z Jaffe
Oct 31, 2008·Current Hypertension Reports·Toshiro Fujita
Jul 3, 2010·Current Hypertension Reports·Yee LuVito M Campese
Jan 6, 2011·Current Hypertension Reports·Shigeru Shibata, Toshiro Fujita
Aug 23, 2011·Journal of Biosciences·Waleska C Dornas, Marcelo E Silva
Mar 21, 2009·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Yoshiyu Takeda
Jun 13, 2009·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Miki Nagase, Toshiro Fujita
Jan 21, 2011·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Shinpei KimuraYoshifusa Aizawa
Apr 10, 2010·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Katsuyuki AndoUNKNOWN Eplerenone combination Versus conventional Agents to Lower blood pressure on Urinary Antialbuminuric Treatment Effect Study
Jun 4, 2010·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Shinji TakaiMizuo Miyazaki
Dec 22, 2006·Nature Clinical Practice. Nephrology·Lucia Del VecchioDaniele Cusi
Jul 24, 2008·Nature Clinical Practice. Nephrology·Matthias Barton
Oct 11, 2008·Nature Reviews. Drug Discovery·Norberto PericoGiuseppe Remuzzi
Mar 18, 2010·Nature Reviews. Nephrology·Marie Briet, Ernesto L Schiffrin
Jan 9, 2013·Nature Reviews. Nephrology·Miki Nagase, Toshiro Fujita
Aug 7, 2013·Nature Reviews. Nephrology·Wiebke FenskeHutan Ashrafian
May 29, 2009·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Eberhard Ritz, Andreas Tomaschitz
May 15, 2010·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Hiroo KawarazakiToshiro Fujita
Aug 24, 2010·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Wei LiangGuohua Ding
Nov 20, 2010·Current Opinion in Nephrology and Hypertension·Eberhard RitzGrzegorz Piecha
Feb 5, 2013·Current Opinion in Nephrology and Hypertension·Miki Nagase
Jan 20, 2010·Clinical and Experimental Pharmacology & Physiology·Yuki MizuguchiHiroshi Itoh
Feb 12, 2009·Development, Growth & Differentiation·Naoki WatanabeYuko Wakamatsu
May 29, 2009·American Journal of Physiology. Renal Physiology·Utpal SenSuresh C Tyagi
Dec 17, 2009·American Journal of Physiology. Renal Physiology·Adam Whaley-ConnellJames R Sowers
Jun 16, 2012·International Journal of Nephrology·Jorge Rojas-RiveraJesus Egido
Apr 9, 2008·Nephron. Experimental Nephrology·Shigetaka YoshidaToshiro Fujita
Jul 11, 2009·Nephron. Experimental Nephrology·Cheng ChenGuohua Ding
Jul 21, 2010·Hypertension·Srinivasa Raju Datla, Kathy K Griendling
Oct 20, 2011·Cardiovascular Diabetology·Markus ReschDierk H Endemann
Sep 22, 2012·Cell & Bioscience·Simran KhuranaHung-Ying Kao
Oct 2, 2012·Endocrinology·Youping Wang, Donna H Wang
Dec 1, 2007·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Shigemoto FujiiHiroaki Kosaka
Mar 25, 2008·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Masaomi Nangaku, Toshiro Fujita
Mar 25, 2008·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Yasutomi HigashikuniMinoru Yamakado

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.